WO2005013955A2 - Topical composition comprising terbinafine and hydrocortisone - Google Patents
Topical composition comprising terbinafine and hydrocortisone Download PDFInfo
- Publication number
- WO2005013955A2 WO2005013955A2 PCT/EP2004/008994 EP2004008994W WO2005013955A2 WO 2005013955 A2 WO2005013955 A2 WO 2005013955A2 EP 2004008994 W EP2004008994 W EP 2004008994W WO 2005013955 A2 WO2005013955 A2 WO 2005013955A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- terbinafine
- hydrocortisone
- gel
- composition according
- topically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04763999A EP1656125A2 (en) | 2003-08-12 | 2004-08-11 | Topical composition comprising terbinafine and hydrocortisone |
CA002535235A CA2535235A1 (en) | 2003-08-12 | 2004-08-11 | Topical composition comprising terbinafine and hydrocortisone |
AU2004262934A AU2004262934B2 (en) | 2003-08-12 | 2004-08-11 | Topical composition comprising terbinafine and hydrocortisone |
JP2006522980A JP2007501832A (en) | 2003-08-12 | 2004-08-11 | Topical composition containing terbinafine and hydrocortisone |
US10/566,874 US20070141089A1 (en) | 2003-08-12 | 2004-08-11 | Topical composition comprising terbinaf ine adn hydrocortisone |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03018271.1 | 2003-08-12 | ||
EP03018271 | 2003-08-12 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2005013955A2 true WO2005013955A2 (en) | 2005-02-17 |
WO2005013955A3 WO2005013955A3 (en) | 2005-04-28 |
WO2005013955A8 WO2005013955A8 (en) | 2005-07-14 |
Family
ID=34717190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/008994 WO2005013955A2 (en) | 2003-08-12 | 2004-08-11 | Topical composition comprising terbinafine and hydrocortisone |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1656125A2 (en) |
JP (1) | JP2007501832A (en) |
AR (1) | AR045241A1 (en) |
AU (1) | AU2004262934B2 (en) |
CA (1) | CA2535235A1 (en) |
PE (1) | PE20050359A1 (en) |
TW (1) | TW200511987A (en) |
WO (1) | WO2005013955A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006103638A2 (en) * | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Topical pharmaceutical compositions of terbinafine and processes for their preparation |
WO2007064181A1 (en) * | 2005-11-30 | 2007-06-07 | Fernando Ahumada Ayala | Nail care preparations containing terbinafine hydrochloride |
WO2007039533A3 (en) * | 2005-09-29 | 2007-08-09 | Novartis Ag | Antifungal composition |
WO2008102349A2 (en) * | 2007-02-21 | 2008-08-28 | Power Paper Ltd | Terbinafine formulation for iontophoresis |
EP2057988A1 (en) * | 2006-08-28 | 2009-05-13 | Hisamitsu Pharmaceutical Co., Inc. | Nail patch |
CN101262848B (en) * | 2005-09-29 | 2011-05-11 | 诺瓦提斯公司 | Antifungal composition |
US10172811B2 (en) | 2013-02-07 | 2019-01-08 | Polichem Sa | Topical antifungal composition for treating onychomycosis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2915534B1 (en) * | 1999-04-23 | 2018-03-14 | Leo Pharma A/S | Pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin D and a corticosteroid |
-
2004
- 2004-08-10 AR ARP040102858A patent/AR045241A1/en not_active Application Discontinuation
- 2004-08-10 PE PE2004000777A patent/PE20050359A1/en not_active Application Discontinuation
- 2004-08-11 CA CA002535235A patent/CA2535235A1/en not_active Abandoned
- 2004-08-11 JP JP2006522980A patent/JP2007501832A/en active Pending
- 2004-08-11 EP EP04763999A patent/EP1656125A2/en not_active Ceased
- 2004-08-11 WO PCT/EP2004/008994 patent/WO2005013955A2/en active Application Filing
- 2004-08-11 AU AU2004262934A patent/AU2004262934B2/en not_active Ceased
- 2004-08-11 TW TW093124093A patent/TW200511987A/en unknown
Non-Patent Citations (3)
Title |
---|
EVANS E G V ET AL: "Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1 percent clotrimazole/1 percent hydrocortisone in clinically diagnosed fungal infection of the skin" BRITISH JOURNAL OF DERMATOLOGY, vol. 129, no. 4, 1993, pages 437-442, XP009022076 ISSN: 0007-0963 * |
ROSEN TED ET AL: "Anti-inflammatory activity of antifungal preparations" INTERNATIONAL JOURNAL OF DERMATOLOGY, vol. 36, no. 10, October 1997 (1997-10), pages 788-792, XP009022078 ISSN: 0011-9059 * |
See also references of EP1656125A2 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006103638A2 (en) * | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Topical pharmaceutical compositions of terbinafine and processes for their preparation |
WO2006103638A3 (en) * | 2005-03-31 | 2007-02-15 | Ranbaxy Lab Ltd | Topical pharmaceutical compositions of terbinafine and processes for their preparation |
CN101262848B (en) * | 2005-09-29 | 2011-05-11 | 诺瓦提斯公司 | Antifungal composition |
WO2007039533A3 (en) * | 2005-09-29 | 2007-08-09 | Novartis Ag | Antifungal composition |
AU2006298748B2 (en) * | 2005-09-29 | 2010-06-03 | Karo Healthcare AB | Antifungal composition |
NO339414B1 (en) * | 2005-09-29 | 2016-12-12 | Novartis Ag | Fungicide |
US10525003B2 (en) | 2005-09-29 | 2020-01-07 | GSK Consumer Healthcare S.A. | Antifungal composition |
WO2007064181A1 (en) * | 2005-11-30 | 2007-06-07 | Fernando Ahumada Ayala | Nail care preparations containing terbinafine hydrochloride |
EP2057988A1 (en) * | 2006-08-28 | 2009-05-13 | Hisamitsu Pharmaceutical Co., Inc. | Nail patch |
EP2057988A4 (en) * | 2006-08-28 | 2009-08-19 | Hisamitsu Pharmaceutical Co | Nail patch |
US8771726B2 (en) | 2006-08-28 | 2014-07-08 | Hisamitsu Pharmaceutical Co., Inc | Nail patch |
WO2008102349A2 (en) * | 2007-02-21 | 2008-08-28 | Power Paper Ltd | Terbinafine formulation for iontophoresis |
WO2008102349A3 (en) * | 2007-02-21 | 2008-11-06 | Power Paper Ltd | Terbinafine formulation for iontophoresis |
US10172811B2 (en) | 2013-02-07 | 2019-01-08 | Polichem Sa | Topical antifungal composition for treating onychomycosis |
Also Published As
Publication number | Publication date |
---|---|
EP1656125A2 (en) | 2006-05-17 |
AR045241A1 (en) | 2005-10-19 |
JP2007501832A (en) | 2007-02-01 |
WO2005013955A3 (en) | 2005-04-28 |
CA2535235A1 (en) | 2005-02-17 |
AU2004262934B2 (en) | 2007-11-29 |
TW200511987A (en) | 2005-04-01 |
WO2005013955A8 (en) | 2005-07-14 |
AU2004262934A1 (en) | 2005-02-17 |
PE20050359A1 (en) | 2005-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1390031B1 (en) | Topical composition containing a fungicide | |
AU2002246119A1 (en) | Topical composition | |
JP4610741B2 (en) | An anhydrous topical skin preparation | |
US10821075B1 (en) | Compositions for topical application of a medicaments onto a mammalian body surface | |
RU2587041C2 (en) | Method of preventing or treating skin tumour | |
JP3331414B2 (en) | Uses of dibutyl adipate and isopropyl myristate in topical or transdermal products | |
MXPA06012426A (en) | Antifungal drug delivery. | |
JP2015530380A (en) | Composition for treating psoriasis | |
AU2004262934B2 (en) | Topical composition comprising terbinafine and hydrocortisone | |
JP2008531640A (en) | Antifungal composition comprising sertaconazole and hydrocortisone and / or antibacterial quinolone compound | |
JP2014516962A (en) | Compositions and methods for the treatment of skin diseases | |
JP5033381B2 (en) | Pharmaceutical composition for external use | |
WO2014138501A2 (en) | Compositions and methods for the treatment of skin diseases | |
JP2007501832A6 (en) | Topical composition containing terbinafine and hydrocortisone | |
CA3162675C (en) | Topical roflumilast formulation having antifungal properties | |
WO2022175985A1 (en) | An eflornithine composition for inhibiting hair growth | |
US20070141089A1 (en) | Topical composition comprising terbinaf ine adn hydrocortisone | |
JP5460766B2 (en) | Pharmaceutical composition for external use | |
CA3100639A1 (en) | Compositions and methods of treatment for moccasin-type and/or interdigital-type tinea pedis | |
WO2001039774A1 (en) | Topical administration of ketotifen | |
BR102012015283A2 (en) | PHARMACOLOGICAL COMPOUND FOR TREATMENT AND REMISSION OF PSORIASIS OR SKIN INJURY AND ITS OBTAINING PROCESS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 07/2005 UNDER (30) REPLACE "US" BY "EP" |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004763999 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004262934 Country of ref document: AU |
|
ENP | Entry into the national phase in: |
Ref document number: 2535235 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006522980 Country of ref document: JP |
|
ENP | Entry into the national phase in: |
Ref document number: 2004262934 Country of ref document: AU Date of ref document: 20040811 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004262934 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004763999 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007141089 Country of ref document: US Ref document number: 10566874 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10566874 Country of ref document: US |
|
ENP | Entry into the national phase in: |
Ref document number: 2004262934 Country of ref document: AU Date of ref document: 20040811 Kind code of ref document: B |